Guillain-Barré syndrome: Difference between revisions

From IDWiki
()
No edit summary
Line 17: Line 17:
===Etiology===
===Etiology===


*''[[Campylobacter jejuni]]''
*''[[Campylobacter jejuni|'''Campylobacter jejuni''']]''
*[[Cytomegalovirus]]
*[[Cytomegalovirus]], [[Haemophilus influenzae]], [[Mycoplasma pneumoniae]], [[Influenza]], [[HIV]]
*Also [[COVID-19]], [[Zika virus]], [[EBV]], [[HSV]], [[VZV]], [[Chikungunya]], [[Escherichia coli]], [[Japanese encephalitis virus]]
*[[Epstein-Barr virus]]
*Non-infectious causes
*[[Zika virus]]
*[[HIV]]
**[[Immunization]]
**Surgery, trauma
*Non-infectious causes, including [[immunization]], surgery, trauma, and [[hematopoietic stem cell transplantation]]
**Medications, including [[TNF-α inhibitors]], [[tacrolimus]], [[suramin]], [[isotretinoin]], and [[immune checkpoint inhibitors]]
**[[Hematopoietic stem cell transplantation]]


=== Pathophysiology ===
=== Pathophysiology ===
Line 41: Line 43:
**[[Campylobacter jejuni]] is the most common causative organism identified
**[[Campylobacter jejuni]] is the most common causative organism identified
**Rare following influenza vaccination; most notable was the 1976 H1N1 vaccine, with about 1 in 100,000 vaccine recipients developing GBS
**Rare following influenza vaccination; most notable was the 1976 H1N1 vaccine, with about 1 in 100,000 vaccine recipients developing GBS

== Differential Diagnosis ==

* [[CIDP]]
* [[Thiamine deficiency]]
* Polyneuropathy, including [[Arsenic poisoning|acute arsenic poisoning]] and other toxin-induced peripheral polyneuropathy, [[Lyme disease]], [[tick paralysis]], [[vasculitis]], [[sarcoidosis]], [[porphyria]]
* [[Leptomeningeal lymphoma]]
* [[Paraneoplastic syndrome]]
* [[Spinal cord disorder]]
* [[Botulism]], [[myasthenia gravis]], [[Lambert-Eaton syndrome]]
* Acute [[polymyositis]], [[dermatomyositis]], [[necrotizing myopathy]], [[critical illness neuropathy]]


==Further Reading==
==Further Reading==

Revision as of 20:07, 22 September 2023

Background

Types

  • Guillain-Barré syndrome
    • Acute inflammatory demyelinating polyneuropathy (AIDP)
    • Acute motor axonal neuropathy
      • Acute motor-sensory axonal neuropathy
      • Acute motor-conduction-block neuropathy
      • Pharyngeal-cervical-branchial weakness
  • Miller Fisher syndrome
    • Incomplete MFS
      • Acute motor-ophthalmoparesis, without ataxia
      • Acute ataxic neyropathy, without ophthalmoparesis
    • Bickerstaff's brainstem encephalitis

Etiology

Pathophysiology

  • Immune crossreactivity causes autoimmune destruction of either the myelin sheath (AIDP) or the axon itself
  • Most common ADAM antibodies are anti-GM1 or anti-GD1a IgG, which recognize gangliosides
  • Most common MFS antibody is anti-GQ1b IgG (in 90%)

Epidemiology

  • About 1 case per 100,000 people per year in Western countries

Clinical Manifestations

  • Ascending paralysis ± sensory involvement
  • Usually occurs 1 to 2 weeks after an immune-stimulating even such as illness or vaccination
    • Preceding illness usually a gastrointestinal or respiratory infection
    • Campylobacter jejuni is the most common causative organism identified
    • Rare following influenza vaccination; most notable was the 1976 H1N1 vaccine, with about 1 in 100,000 vaccine recipients developing GBS

Differential Diagnosis

Further Reading